Clinical Trial Update: Minimally Invasive Control of Epistaxis (MICE) [Phase 2, Phase 3]

View source ↗

Summary

The Minimally Invasive Control of Epistaxis (MICE) trial, conducted in Phase 2 and Phase 3 and sponsored by the University of Calgary, has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epistaxis

Snippet

Sponsor: University of Calgary | Conditions: Epistaxis | Phase 2, Phase 3 | Status: TERMINATED